Lucira Health, Inc.
NASDAQ: LHDX0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Erik T. Engelson
- Employees
- 221
- Headquarters
- EmeryVille, United States
- IPO year
- 2021
- Market cap
- $18.4M
- Website
- https://www.lucirahealth.com
Loading LHDX…
Loading profile data…Frequently asked questions about LHDX
What does Lucira Health, Inc. (LHDX) do?
Lucira Health, Inc. is a medical technology enterprise dedicated to the development and commercialization of diagnostic test kits for infectious diseases. The company has innovated a platform capable of providing molecular testing capabilities. Among its current product offerings is the LUCIRA COVID-19 All-In-One Test Kit, and it is also progres...
Where does LHDX trade?
Lucira Health, Inc. (LHDX) trades on the NASDAQ Global Select.
What sector is LHDX in?
Lucira Health, Inc. (LHDX) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of Lucira Health, Inc.?
Erik T. Engelson is the chief executive officer of Lucira Health, Inc. (LHDX).
Where is Lucira Health, Inc. headquartered?
Lucira Health, Inc. is headquartered in United States.
Does LHDX pay a dividend?
Lucira Health, Inc. (LHDX) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did LHDX go public?
Lucira Health, Inc. (LHDX) completed its initial public offering in 2021.